A recent study published in Aging Cell has revealed significant insights into the relationship between astrocyte-derived molecules and normal brain aging, particularly contrasting effects in the context of Alzheimer's disease. Researchers focused on two related molecules, Hevin and SPARC, shedding light on their roles in synaptic maintenance and development.

Hevin vs. SPARC

Astrocytes, the versatile support cells in the brain, play a crucial role in maintaining synaptic integrity by secreting various molecules, including members of the SPARC family. These molecules exhibit opposing functions: Hevin promotes new synapse formation, whereas SPARC inhibits this process. Notably, SPARC upregulation has been associated with the advancement of Alzheimer’s disease, while Hevin levels appear to decline in affected individuals

“Understanding the balance between Hevin and SPARC is key to developing potential therapeutic strategies for age-related cognitive decline.”

Effects in Both Alzheimer’s and Wild-Type Mice

In an exploratory study, researchers initially investigated middle-aged APP/SEN mice, which are genetically modified to produce Alzheimer’s proteins, alongside an RNA database containing information from astrocytes of Alzheimer’s patients. The results found a significant downregulation of Hevin in the Alzheimer’s cohort.

Subsequently, the researchers injected the APP/SEN mice with an adeno-associated virus (AAV) designed to induce Hevin overexpression. Following a treatment period of five to six months, cognitive tests were conducted, assessing both APP/SEN and wild-type mice. Results indicated substantial improvements in cognitive performance in the Hevin-overexpressing mice, as highlighted in the various tests performed:

Test Type Control Group Performance Hevin-Injected Performance
Novel Object Recognition Low Interest High Interest
Barnes Maze Test Slow Learners Fast Learners

Different Mechanisms of Action

Remarkably, while Hevin appeared to enhance cognitive function, it did not affect amyloid beta deposits in APP/SEN mice. Four brain regions were analyzed post-treatment, and no significant differences in amyloid levels were observed. However, notable alterations in gene expression were recorded, with implications on cognitive performance and synaptic development.

The research comparing wild-type mice yielded distinct alterations, primarily concerning actin organization, a protein integral to synaptic structuring. This suggests diverse mechanisms by which Hevin impacts cognitive functions in both Alzheimer's and non-Alzheimer's contexts.

Group Type Gene Expression Changes
APP/SEN Mice Changes linked to cognition and synaptic development
Wild-Type Mice Changes mainly related to actin organization

Implications and Future Directions

These findings open doors for further exploration into the therapeutic potential of Hevin, particularly for older adults experiencing cognitive decline unrelated to Alzheimer’s. However, the direct application of these results to human trials poses unique challenges, especially considering the mouse-specific nature of the treatment.

Future research may explore whether Hevin can be a viable target for drug development or mRNA-based therapies. The underlying mechanisms by which Hevin could be harnessed for cognitive enhancements remain an essential area for continued investigation.

Literature Cited

  • [1] Lawal, O., Ulloa Severino, F. P., & Eroglu, C. (2022). The role of astrocyte structural plasticity in regulating neural circuit function and behavior. Glia, 70(8), 1467-1483.
  • [2] Tan, C. X., Lane, C. J. B., & Eroglu, C. (2021). Role of astrocytes in synapse formation and maturation. Current Topics in Developmental Biology, 142, 371-407.
  • [3] Kucukdereli, H., et al. (2011). Control of excitatory CNS synaptogenesis by astrocyte-secreted proteins Hevin and SPARC. Proceedings of the National Academy of Sciences, 108(32), E440-E449.
  • [4] Singh, S. K., et al. (2016). Astrocytes assemble thalamocortical synapses by bridging NRX1α and NL1 via Hevin. Cell, 164(1), 183-196.
  • [5] Gan, K. J., & Südhof, T. C. (2019). Factors in blood from young but not old mice promote synapse formation. Proceedings of the National Academy of Sciences, 116(25), 12524-12533.
  • [6] Lai, W. F., & Wong, W. T. (2020). Roles of the actin cytoskeleton in aging and age-associated diseases. Ageing Research Reviews, 58, 101021.